Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METHOTREXATE Cause Nervous system disorder? 489 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 489 reports of Nervous system disorder have been filed in association with METHOTREXATE (Methotrexate). This represents 0.2% of all adverse event reports for METHOTREXATE.

489
Reports of Nervous system disorder with METHOTREXATE
0.2%
of all METHOTREXATE reports
74
Deaths
124
Hospitalizations

How Dangerous Is Nervous system disorder From METHOTREXATE?

Of the 489 reports, 74 (15.1%) resulted in death, 124 (25.4%) required hospitalization, and 16 (3.3%) were considered life-threatening.

Is Nervous system disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METHOTREXATE. However, 489 reports have been filed with the FAERS database.

What Other Side Effects Does METHOTREXATE Cause?

Drug ineffective (70,142) Rheumatoid arthritis (29,254) Off label use (24,020) Pain (23,773) Drug intolerance (22,555) Arthralgia (21,831) Fatigue (19,885) Nausea (18,715) Joint swelling (17,657) Drug hypersensitivity (16,677)

What Other Drugs Cause Nervous system disorder?

ADALIMUMAB (653) CIPROFLOXACIN (449) ACETAMINOPHEN\PROPOXYPHENE (399) PROPOXYPHENE (399) RITUXIMAB (389) ETANERCEPT (361) CYCLOPHOSPHAMIDE (357) DEXAMETHASONE (346) LEVOFLOXACIN (323) PREDNISONE (310)

Which METHOTREXATE Alternatives Have Lower Nervous system disorder Risk?

METHOTREXATE vs METHOXSALEN METHOTREXATE vs METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA METHOTREXATE vs METHYL ALCOHOL METHOTREXATE vs METHYLCOBALAMIN METHOTREXATE vs METHYLDOPA

Related Pages

METHOTREXATE Full Profile All Nervous system disorder Reports All Drugs Causing Nervous system disorder METHOTREXATE Demographics